Director at Lam Research (NASDAQ: LRCX) sells 54,500 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
LAM RESEARCH CORP director Eric Brandt reported a series of open‑market sales of company common stock. On June 11, 2026, he sold a total of 54,500 shares in multiple transactions under a pre‑arranged Rule 10b5‑1 trading plan adopted on February 6, 2026.
The reported weighted‑average sale prices for these trades ranged from about $337 to $364 per share. Following the transactions, Brandt directly owned 199,205 shares of Lam Research common stock, and this amount includes shares subject to unvested restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 54,500 shares ($19,118,360)
Net Sell
26 txns
Insider
BRANDT ERIC
Role
null
Sold
54,500 shs ($19.12M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 974 | $337.56 | $329K |
| Sale | Common Stock | 1,083 | $338.62 | $367K |
| Sale | Common Stock | 1,895 | $339.75 | $644K |
| Sale | Common Stock | 1,277 | $340.68 | $435K |
| Sale | Common Stock | 1,070 | $341.81 | $366K |
| Sale | Common Stock | 3,644 | $342.91 | $1.25M |
| Sale | Common Stock | 1,481 | $343.96 | $509K |
| Sale | Common Stock | 3,208 | $344.92 | $1.11M |
| Sale | Common Stock | 2,832 | $345.84 | $979K |
| Sale | Common Stock | 3,442 | $346.79 | $1.19M |
| Sale | Common Stock | 6,592 | $347.86 | $2.29M |
| Sale | Common Stock | 4,334 | $348.73 | $1.51M |
| Sale | Common Stock | 1,517 | $349.79 | $531K |
| Sale | Common Stock | 36 | $350.77 | $13K |
| Sale | Common Stock | 1,172 | $353.52 | $414K |
| Sale | Common Stock | 1,461 | $354.08 | $517K |
| Sale | Common Stock | 1,331 | $355.50 | $473K |
| Sale | Common Stock | 1,653 | $356.27 | $589K |
| Sale | Common Stock | 1,455 | $357.06 | $520K |
| Sale | Common Stock | 1,880 | $358.22 | $673K |
| Sale | Common Stock | 780 | $359.24 | $280K |
| Sale | Common Stock | 664 | $360.24 | $239K |
| Sale | Common Stock | 1,756 | $361.05 | $634K |
| Sale | Common Stock | 2,604 | $362.20 | $943K |
| Sale | Common Stock | 5,717 | $362.95 | $2.07M |
| Sale | Common Stock | 642 | $364.00 | $234K |
Holdings After Transaction:
Common Stock — 252,731 shares (Direct, null)
Footnotes (1)
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $337.00 to $337.97, inclusive The amount reported includes shares subject to unvested restricted stock units. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.19 to $339.15, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $339.23 to $340.20, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $340.278 to $341.249, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $341.418 to $342.202, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $342.415 to $343.39, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $343.40 to $344.377, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $344.396 to $345.348, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $345.386 to $346.336, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $346.383 to $347.359, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $347.383 to $348.355, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $348.391 to $349.351, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $349.409 to $350.260, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $352.824 to $353.805, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $353.818 to $354.743, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $354.805 to $355.746, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.75 to $356.709, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.759 to $357.703, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.762 to $358.70, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.79 to $359.735, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.819 to $360.59, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.60 to $361.54, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.595 to $362.550, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $362.58 to $363.57, inclusive The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.765 to $364.37, inclusive
Key Figures
Shares sold: 54,500 shares
Post-transaction holdings: 199,205 shares
Highest reported sale price: $364.00 per share
+3 more
6 metrics
Shares sold
54,500 shares
Total open‑market sales on <date>June 11, 2026</date>
Post-transaction holdings
199,205 shares
Common stock directly owned after transactions, including unvested RSUs
Highest reported sale price
$364.00 per share
One of multiple weighted‑average prices on <date>June 11, 2026</date>
Lowest referenced trade range
$337.00–$337.97 per share
Price range from one weighted‑average sale footnote
Number of sale transactions
26 entries
Count of reported open‑market sale line items in Form 4
Trading plan adoption date
February 6, 2026
Date Eric Brandt adopted Rule 10b5‑1 trading plan
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, unvested restricted stock units, open-market sale
4 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price"
unvested restricted stock units financial
"The amount reported includes shares subject to unvested restricted stock units"
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What insider transaction did LAM RESEARCH CORP (LRCX) report for Eric Brandt?
LAM RESEARCH CORP reported that director Eric Brandt sold 54,500 shares of common stock. The transactions were open‑market sales executed on June 11, 2026 under a Rule 10b5‑1 trading plan previously adopted on February 6, 2026.
Do Eric Brandt’s Lam Research (LRCX) holdings include unvested restricted stock units?
Yes. A footnote clarifies that the amount reported as directly owned by Eric Brandt includes shares subject to unvested restricted stock units. These units represent equity awards that will convert into shares according to their vesting conditions and schedule.